Allarity Therapeutics Gross Profit vs. EBITDA

ALLR Stock  USD 1.11  0.05  4.72%   
Based on Allarity Therapeutics' profitability indicators, Allarity Therapeutics may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Allarity Therapeutics' ability to earn profits and add value for shareholders.
 
Gross Profit  
First Reported
2010-12-31
Previous Quarter
-37 K
Current Value
-38.9 K
Quarterly Volatility
98.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
As of 12/05/2024, Price To Sales Ratio is likely to drop to 228.54. In addition to that, Days Sales Outstanding is likely to drop to 4,034. At this time, Allarity Therapeutics' Interest Income is relatively stable compared to the past year. As of 12/05/2024, Total Other Income Expense Net is likely to grow to about 5.6 M, while Accumulated Other Comprehensive Income is likely to drop (431.6 K).
For Allarity Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Allarity Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Allarity Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Allarity Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Allarity Therapeutics over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
To learn how to invest in Allarity Stock, please use our How to Invest in Allarity Therapeutics guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allarity Therapeutics. If investors know Allarity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allarity Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.98)
Revenue Per Share
(0.02)
Return On Assets
(0.48)
Return On Equity
(1.22)
The market value of Allarity Therapeutics is measured differently than its book value, which is the value of Allarity that is recorded on the company's balance sheet. Investors also form their own opinion of Allarity Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Allarity Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allarity Therapeutics' market value can be influenced by many factors that don't directly affect Allarity Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allarity Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allarity Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allarity Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Allarity Therapeutics EBITDA vs. Gross Profit Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Allarity Therapeutics's current stock value. Our valuation model uses many indicators to compare Allarity Therapeutics value to that of its competitors to determine the firm's financial worth.
Allarity Therapeutics is rated below average in gross profit category among its peers. It is rated below average in ebitda category among its peers . At this time, Allarity Therapeutics' Gross Profit is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Allarity Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Allarity EBITDA vs. Gross Profit

Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Allarity Therapeutics

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
(36.35 M)
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Allarity Therapeutics

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(12.08 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Allarity EBITDA Comparison

Allarity Therapeutics is currently under evaluation in ebitda category among its peers.

Allarity Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Allarity Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Allarity Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Allarity Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Allarity Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-411 K-431.6 K
Net Loss-24.2 M-25.4 M
Income Tax Expense-717 K-752.9 K
Net Interest Income-354 K-371.7 K
Interest Income34.5 K36.2 K
Operating Income-17.9 M-18.8 M
Net Loss-13 M-13.7 M
Income Before Tax-12.6 M-13.2 M
Total Other Income Expense Net5.3 M5.6 M
Net Loss-11.9 M-12.5 M
Non Operating Income Net Other15.2 M13.5 M
Change To Netincome19 M12.7 M
Net Loss(0.01)(0.01)
Income Quality 1.07  0.77 
Net Income Per E B T 0.94  0.69 

Allarity Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Allarity Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Allarity Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Allarity Therapeutics' important profitability drivers and their relationship over time.

Use Allarity Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allarity Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Allarity Therapeutics Pair Trading

Allarity Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Allarity Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allarity Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allarity Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allarity Therapeutics to buy it.
The correlation of Allarity Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allarity Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allarity Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allarity Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Allarity Therapeutics position

In addition to having Allarity Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Money Market Funds Thematic Idea Now

Money Market Funds
Money Market Funds Theme
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Allarity Stock Analysis

When running Allarity Therapeutics' price analysis, check to measure Allarity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allarity Therapeutics is operating at the current time. Most of Allarity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allarity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allarity Therapeutics' price. Additionally, you may evaluate how the addition of Allarity Therapeutics to your portfolios can decrease your overall portfolio volatility.